The ASF Medical Advisory Board is made up of members of the Angelman community who are medical professionals, researchers, and specialists who have in-depth knowledge and experience in diagnosing, treating and researching Angelman syndrome.

The board plays a crucial role in establishing treatment and care standards for individuals with the AS. They review and evaluate existing guidelines, research findings and emerging therapies to ensure that patients receive the best possible care. They contribute to the development of educational materials, patient resources, and healthcare provider training programs. By disseminating accurate and up-to-date information, they empower patients, families, and healthcare professionals to better understand and manage AS. Members review proposals for discovery grants, the Jacob Pritzker fellowship program, and provide guidance in working with medical institutions.

In addition, the Medical Advisory Board plays a key role in shaping and guiding the Ladder Learning Network (LLN), a national clinical care network powered by ASF to advance evidence-based care and access for individuals with Angelman syndrome. The board helps ensure that LLN clinics are aligned with the latest research, clinical guidelines, and priorities of Angelman families. By advising on best practices, provider education, and care standards, the Medical Advisory Board helps elevate the quality and consistency of care across the network—ultimately improving outcomes and quality of life for individuals with AS and their families.